GoHealth, Inc.

NasdaqCM:GOCO Stock Report

Market Cap: US$74.6m

GoHealth Valuation

Is GOCO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GOCO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate GOCO's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate GOCO's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GOCO?

Key metric: As GOCO is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for GOCO. This is calculated by dividing GOCO's market cap by their current revenue.
What is GOCO's PS Ratio?
PS Ratio0.06x
SalesUS$738.34m
Market CapUS$74.64m

Price to Sales Ratio vs Peers

How does GOCO's PS Ratio compare to its peers?

The above table shows the PS ratio for GOCO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.9x
HIT Health In Tech
2.9x44.19%US$88.5m
EHTH eHealth
0.2x4.33%US$122.1m
CCG Cheche Group
0.2x13.73%US$81.2m
AIFU AIFU
0.4xn/aUS$63.5m
GOCO GoHealth
0.06x9.31%US$74.6m

Price-To-Sales vs Peers: GOCO is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (1x).

Price to Sales Ratio vs Industry

How does GOCO's PS Ratio compare vs other companies in the US Insurance Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.1.1x5.1%
GOCO GoHealth
 0.06x9.31%US$74.64m
SLQT SelectQuote
0.2x8.81%US$274.52m
CCG Cheche Group
0.2x13.73%US$81.15m
GOCO 0.1xIndustry Avg. 1.1xNo. of Companies23PS00.81.62.43.24+
5 CompaniesEstimated GrowthMarket Cap
Industry Avg.1.1x6.8%
GOCO GoHealth
 0.06x137.74%US$74.64m
No more companies

Price-To-Sales vs Industry: GOCO is good value based on its Price-To-Sales Ratio (0.1x) compared to the US Insurance industry average (1.1x).

Price to Sales Ratio vs Fair Ratio

What is GOCO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GOCO PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.06x
Fair PS Ratio1.3x

Price-To-Sales vs Fair Ratio: GOCO is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GOCO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$2.54
US$17.20
+578.50%
20.27%US$22.00US$12.00n/a5
Nov ’26US$3.96
US$17.20
+334.34%
20.27%US$22.00US$12.00n/a5
Oct ’26US$4.77
US$17.20
+260.59%
20.27%US$22.00US$12.00n/a5
Sep ’26US$5.11
US$17.20
+236.59%
20.27%US$22.00US$12.00n/a5
Aug ’26US$5.56
US$21.60
+288.49%
11.93%US$25.00US$18.00n/a5
Jul ’26US$5.92
US$21.60
+264.86%
11.93%US$25.00US$18.00n/a5
Jun ’26US$5.51
US$21.60
+292.01%
11.93%US$25.00US$18.00n/a5
May ’26US$9.44
US$26.00
+175.42%
32.52%US$40.00US$18.00n/a4
Apr ’26US$12.39
US$26.00
+109.85%
32.52%US$40.00US$18.00n/a4
Mar ’26US$14.49
US$21.00
+44.93%
23.33%US$25.00US$13.00n/a4
Feb ’26US$16.30
US$19.50
+19.63%
23.08%US$25.00US$13.00n/a4
Jan ’26US$13.39
US$19.50
+45.63%
23.08%US$25.00US$13.00n/a4
Dec ’25US$12.81
US$19.50
+52.22%
23.08%US$25.00US$13.00n/a4
Nov ’25US$11.71
US$17.67
+50.93%
20.84%US$22.00US$13.00US$3.963
Oct ’25US$9.12
US$17.67
+93.71%
20.84%US$22.00US$13.00US$4.773
Sep ’25US$8.46
US$17.67
+108.83%
20.84%US$22.00US$13.00US$5.113
Aug ’25US$12.69
US$18.33
+44.47%
21.05%US$22.00US$13.00US$5.563
Jul ’25US$10.44
US$18.33
+75.61%
21.05%US$22.00US$13.00US$5.923
Jun ’25US$10.47
US$18.33
+75.10%
21.05%US$22.00US$13.00US$5.513
May ’25US$11.00
US$18.33
+66.67%
21.05%US$22.00US$13.00US$9.443
Apr ’25US$10.65
US$17.50
+64.32%
25.71%US$22.00US$13.00US$12.392
Mar ’25US$12.85
US$21.00
+63.42%
4.76%US$22.00US$20.00US$14.492
Feb ’25US$12.33
US$21.00
+70.32%
4.76%US$22.00US$20.00US$16.302
Nov ’24US$14.02
US$19.79
+41.12%
1.09%US$20.00US$19.57US$11.712
US$17.2
Fair Value
85.3% undervalued intrinsic discount
5
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/14 14:55
End of Day Share Price 2025/11/14 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

GoHealth, Inc. is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steven ValiquetteBarclays
Steven ValiquetteBarclays
Michael ChernyBofA Global Research